Compound information
- Natural Products
- ZC1662613
- Molecular Formula
- C15H20ClNO3
- Molecular Weight
- 297.11317118 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-(2-chloroacetyl)-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C15H20ClNO3/c1-11(2)8-13(14(18)9-16)17-15(19)20-10-12-6-4-3-5-7-12/h3-7,11,13H,8-10H2,1-2H3,(H,17,19)/t13-/m1/s1
- InChI Key
- FZWQHSCPNKTIRU-CYBMUJFWSA-N
- SMILES
- CC(C)C[C@@H](NC(=O)OCc1ccccc1)C(=O)CCl
- Source
- ZINC000086860300
Warheads
- Carbonyl
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 55.4 Å2 | LogP | 3.23 |
LogS | -3.815 | LogD | 2.983 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.201 | Pgp substrate | 0.006 |
HIA | 0.964 | F20 % | 0.993 |
F30 % | 0.948 | Caco-2 | -4.391 |
MDCK | -4.614 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.965 | PPB | 51.764 |
VD | 0.741 | Fu | 1.033 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.981 | CYP1A2 substrate | 0.627 |
CYP2A6 substrate | 0.468 | CYP2B6 substrate | 0.627 |
CYP2C19 inhibitor | 0.943 | CYP2C19 substrate | 0.8 |
CYP2C8 substrate | 0.725 | CYP2C9 inhibitor | 0.728 |
CYP2C9 substrate | 0.995 | CYP2D6 inhibitor | 0.007 |
CYP2D6 substrate | 0.335 | CYP2E1 substrate | 0.292 |
CYP3A4 inhibitor | 0.471 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.876 | CL | 6.673 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.981 |
Mutagenicity | 0.866 | Rat Oral Acute Toxicity | 0.038 |
FDAMDD | 0.162 | Skin Sensitization | 0.956 |
Carcinogenicity | 0.056 | Eye Corrosion | 0.485 |
Eye Irritation | 0.332 | Respiratory Toxicity | 0.983 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.001 | IGC50 | 3.571 |
LC50FM | 4.631 | LC50DM | 5.674 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.125 | NR-AR-LBD | 0.849 |
NR-AhR | 0.003 | NR-Aromatase | 0.045 |
NR-ER | 0.259 | NR-ER-LBD | 0.408 |
NR-PPAR-gamma | 0.902 | SR-ARE | 0.904 |
SR-ATAD5 | 0.857 | SR-HSE | 0.284 |
SR-MMP | 0.026 | SR-p53 | 0.436 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.